Antibody testing shows whether you've had the COVID-19 virus in the past. It's not the same as testing to see whether you have the virus now.

In the ongoing Omicron era, a new Covid-19 antibody could renew optimism for urgently required SARS-CoV-2 monoclonal therapies. Over the last three years, various ...

Researchers discover that the COVID-19 virus can trigger the production of 'abzymes' -- antibodies that act like enzymes -- which may explain why long COVID symptoms persist even after the infection ...

A monoclonal antibody appears effective at neutralizing the numerous variants of SARS-CoV-2, as well as related viruses in animals that could pose a threat if they were to begin spreading in people.

Two healthcare workers get COVID-19 vaccinations on the same day. Both show strong antibody responses initially, but six months later one stays healthy while the other contracts the virus. A new study ...

Although the COVID-19 pandemic has largely subsided, scientists continue to investigate why the virus proved so deadly, ...

In front of a basketball court, an A-frame sign reads “monoclonal antibody site” with arrows pointing to the right. Monoclonal antibodies were a common treatment for COVID-19 early in the pandemic.

Recently, scientists found that some people who suffered from COVID-19 had auto-antibodies targeting their own type 1 interferons, which are important immune signaling proteins. Now, researchers ...

Although the COVID-19 pandemic has largely subsided, scientists continue to investigate why the virus proved so deadly, ...

UVA Health researchers have discovered a potential explanation for some of the most perplexing mysteries of COVID-19 and long COVID. The surprising findings could lead to new treatments for the ...